We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

CNS
Digital Poster
Clinical
Validation of the clinical practicability of the GPA for NSCLC patients with BMs treated with GKRS.
Iglika MIHAYLOVA, Bulgaria
E25-30
New enhancement following central nonenhancement as a radiological predictor of persistent growth of vestibular schwannomas following radiotherapy
Masahiro Yamazaki, Japan
E25-426
Clinical outcome and Deep learning imaging characteristics of patients treated by radio-chemotherapy for a “molecular” glioblastoma
Benjamin Cavallier, France
E25-456
Survival advantage of Boron Neutron Capture Therapy in recurrent glioblastoma: A propensity-matched analysis
Shuo-Fu Chen, Taiwan, Province of China
E25-545
Impact of gamma knife radiosurgery dose-rate on patient outcomes: a systematic review and meta-analysis
Jane Jomy, Canada
E25-558
Evaluation of a fractionated stereotactic postoperative radiotherapy regimen for brain metastasis
Sebastian Maier, Germany
E25-581
Clinical outcomes of C-arm linear accelerator-based stereotactic radiosurgery for cerebral arteriovenous malformation
Yotdanai Namuangchan, Thailand
E25-723
Treatment outcomes and predictive value of planning metrics after Gamma Knife stereotactic radiosurgery for intracranial chordoma and chondrosarcoma
Joseph Adedigba, USA
E25-802
A feasibility trial of delayed resection for brain metastases following pre-operative stereotactic radiosurgery
Christina Schröder, Switzerland
E25-886
Neuroprotection in radiotherapy of brain metastases – a European pattern-of-care analysis by the ESTRO CNS Focus Group
Nils Gleim, Germany
E25-999
Postoperative radiosurgery (SRS) vs hypofractionated stereotactic radiotherapy (HFSRT) for resected brain metastases – a single centre analysis
Lena Kretzschmar, Switzerland
E25-54
Outcomes of whole-brain radiotherapy with stereotactic boost using HyperArc mono-isocentric radiosurgery: a single-institution study of 105 patients.
Camille Streiff, France
E25-1457
Refining optic neuropathy in patients undergoing pencil beam scanning proton therapy
Juliette Thariat, France
E25-1462
Clinical Efficacy and Volumetric Evolution of Pituitary Neuroendocrine Tumors Normofractionated External Irradiation
Georges Noel, France
E25-1491
Clinical outcomes and QoL in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5T MR-Linac in an Australian setting
Kurl Jamora, Australia
E25-1507
Novel frameless thalamotomy on CyberKnife S7 treatment delivery system in general anesthesia
Ivana Alerić, Croatia
E25-1512
Radiomic analysis for differential diagnosis of radiation necrosis and tumor progression following stereotactic radiosurgery in brain metastases
Beatriz Vázquez Barreiro, Spain
E25-1525
Comparative analysis of 3DCRT, IMRT and Helical Tomotherapy in Glioblastoma: Evaluation of recurrence dynamics
Sweekruti Hegde, India
E25-67
Clinical target volume threshold for dose reduction from 60 Gy to 54 Gy in extensive glioblastoma
Kurl Jamora, Australia
E25-1571
The importance of being united: impact of neuro-oncology multidiciplinary boards on radiation oncology decision making - a one-year review
Nicola Dinapoli, Italy
E25-1686
Gamma Knife radiosurgery for sporadic vestibular Schwannoma: volumetric response analysis
Chiara Mattioli, Italy
E25-1962
Outcomes of reirradiation for recurrent high-grade gliomas: a retrospective analysis of dose and timing effects on survival
INES OLLINGER, Spain
E25-1974
A representative pattern for radiation-induced cerebral contrast enhancements post intensity modulated proton therapy treatment
Rupesh Kotecha, USA
E25-2024
Features of PET/CT with fluoroethyltyrosine interpretation after proton radiation therapy of patients with IDH wildtype glioblastoma
Nikita Kataev, Russian Federation
E25-2110
Randomized Phase II Trial: Hippocampal Avoidance Whole Brain Radiotherapy With or Without Simultaneous Integrated Boost in Brain Metastases
Amitayus Lim, Singapore
E25-2261
Neurocognition and quality of life in patients receiving conformal cranial radiotherapy for brain metastases: A prospective study
Preetha Umesh, India
E25-2309
Prognostic factors in single-isocenter linac-based SRT for brain metastases: does dose distribution or patient selection matter more?
Valeria Faccenda, Italy
E25-117
Feasibility Study of Multicentric Diffusion Tensor Imaging for Identifying New Organs at Risk in Intracranial Stereotactic Radiotherapy
Paul RETIF, France
E25-2357
Inter-observer variability in glioblastoma target delineation – A national study
Anders Schwartz Vittrup, Denmark
E25-2404
The impact of antineoplastic therapy before and after WBRT for non-small cell lung cancer and breast cancer patients with meningeosis carcinomatosa
Michael Schmeling, Germany
E25-2509
EFFICACY AND SAFETY OF A SECOND COURSE OF WHOLE-BRAIN RADIOTHERAPY FOR MULTIPLE BRAIN METASTASES: KEY DETERMINANTS FOR PATIENT SELECTION
Gonçalo Códia Nicolau, Brazil
E25-2560
Stereotactic Radiotherapy in Brain Metastases: SRS/FSRT Paradox and Preferences of Radiation Oncologists in Turkey (TROD 10-010 Study)
Caglayan Selenge Beduk Esen, Turkey
E25-2599
Stereotactic Radiosurgery of Brain Metastases from Cancers that Rarely Metastasize to the Central Nervous System
Banu Atalar, Turkey
E25-2604
Does retinoic acid-induced growth-response influence the outcome of irradiation in glioblastoma cells?
Theresa O'Donovan, Ireland
E25-2827
Dose-Related Vestibular Toxicity and Optimization in Stereotactic Radiosurgery for Vestibular Schwannomas
Sébastien Tran, Switzerland
E25-2851
Clinical Impact of Integrating 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases in the Post-Whole Brain Radiotherapy Setting
EYUB YASAR AKDEMIR, USA
E25-235
Overall survival of patients with ten or more brain metastases treated with SRS.
Maciej Blok, Poland
E25-2995
Differential Utilization and Spending for Conventional Radiotherapy vs. Stereotactic Radiosurgery for Brain Metastases Among Older Adults in the US
Kathryn Tringale, USA
E25-3010
Black Blood MRI: The secret weapon for contouring agreement
Gloria Sanchez Naranjo, Spain
E25-3051
Addition of 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases Prolongs Time to Next Intervention
EYUB YASAR AKDEMIR, USA
E25-3202
Analysis of radiotherapy in intermediate and high-risk meningiomas : outcomes and prognostic factors
Jisang Kim, Korea Republic of
E25-3261
The infratentorial localization of brain metastases in non-small cell lung cancer indicates a poorer prognosis and distinct prognostic factors
Zheqing Liu, China
E25-3308
Impact of Stereotactic Radiosurgery Doses on Local Control and Radiation Necrosis in Metastatic Brain Lesions: A Comparative Study
Mohammad Mukahal, Jordan
E25-3323
Multidisciplinary management of 121 Spinal Ependymomas-single institutional experience from a specialized neuro-oncology practice in India
ABHISHEK CHATTERJEE, India
E25-331
Impact of dosimetric parameters analysis in fractionated radiotherapy for brain metastasis.
Victoria Vera Barragán, Spain
E25-3459
Efficacy and safety of postoperative hypofractionated stereotactic radiotherapy for resected brain metastases: a single-centre experience
Anna Lucas , Spain
E25-3591
Impact of resection extent and adjuvant radiotherapy in atypical meningioma WHO grade II
Yotdanai Namuangchan, Thailand
E25-3611
Exploration of the Efficacy and Safety of Anlotinib Combined with Radiotherapy in Treating Newly Diagnosed Pediatric Malignant Brainstem Glioma
Yuan-yuan Chen, China
E25-3683
Is MR imaging necessary for producing clinically appropriate hippocampal contours for HA-WBRT?
Owen Rodrigues, Canada
E25-3803
Comparative Analysis of and Clinical Outcomes in Adult Craniospinal Irradiation: Tomotherapy Versus Published Data on Tomotherapy and Proton Therapy
Jesus Romero Fernandez, Spain
E25-3805
Clinical outcomes in patients with HER2-positive Breast Cancer Brain Metastases treated with Stereotactic Radiosurgery
Guhan Rangaswamy, Ireland
E25-3808
Hit-and-miss no more: Improving contouring precision in brain metastases using black blood MRI sequences
Rafael D'Ambrosi, Spain
E25-342
INDIGO – an innovative proton therapy concept for low-grade glioma patients tested multicentrically in a prospective randomized trial
Julia Bauer, Germany
E25-3839
Refractory SPAsticity and hypertonia or spasms treated with steReoTActic radiosurgery (SPARTA)
Luca Nicosia, Italy
E25-3873
Dose-escalated re-irradation of recurrent glioma – Analysis of risk of radionecrosis and symptomatic edema
Daniel Fleischmann, Germany
E25-3904
Coverage of the target volume in radiotherapy planning and FET-PET parameters as prognostic factors for patients with High Grade Glioma: GLIRARP Study
Silvia Scoccianti, Italy
E25-4063
Hypofractionated radiosurgery for functioning and non-functioning pituitary adenomas after surgery: Our working experience with Cyberknife unit.
Julen Azcona Martin, Spain
E25-4071
THE PROGNOSTIC ROLE OF PRETREATMENT BLOOD CELLS RATIOS IN CHEMORADIOTHERAPY TREATED GLIOBLASTOMA
Marco Lucarelli, Italy
E25-4081
The efficacy of CyberKnife® stereotactic radiation therapy in re-irradiation of recurrent glioblastoma.
Hanna Grzbiela, Poland
E25-4197
Is dose escalation necessary for patients with glioblastoma who are to be treated with radiotherapy? A single-institutional descriptive analysis.
ALBA GALATEA CURBELO ARTILES, Spain
E25-4242
The Neurocognitive Effects of Intracranial Progression & Subsequent Courses of Stereotactic Radiosurgery: Lessons Learned from a Prospective Registry
EYUB YASAR AKDEMIR, USA
E25-344
Re-irradiation After Re-surgery in Recurrent Glioblastoma: A Viable Strategy? Evaluating Its Role in Improving Survival Outcomes
Nicola Dinapoli, Italy
E25-4243
Consecutive radiosurgery for multiple brain metastases with CyberKnife Robotic Radiosurgery Unit: Outcomes and Predictive Factors at a Hospital Center
Julen Azcona Martin, Spain
E25-4246
Advancing Pediatric Radiotherapy: Integrating AI-Driven Radiomics and Global Collaboration to Enhance Precision and Humanize Care
Aida Angela Tummolo , Italy
E25-4248
Impact of radiotherapy on verbal memory: short and long-term effects in cerebral meningioma patients
Karan Jangbahadoer Sing, The Netherlands
E25-4289
10 years of SRS Single isocenter to multiple brain metastases Results
Claudia Menichelli, Italy
E25-4291
Beyond the treatment: lasting outcomes of fractionated stereotactic radiotherapy in pituitary adenoma
Jesus Romero Fernandez, Spain
E25-4307
Predictive Factors for Radiation-Induced Facial Spasms, Toxicities, and Long-Term Outcomes of Stereotactic Radiotherapy in Vestibular Schwannoma
Danielle Eekers, The Netherlands
E25-4311
Evaluating the Impact of Adjuvant Temozolomide Duration on Survival Outcomes in Low-Grade Gliomas: A Clinical audit from tertiary care centre
Arnav Tiwari, India
E25-4325
International Multicenter Evaluation of Limbic System Coverage in Radiation Treatment Planning for High-Grade Glioma
Lara Caglayan, Germany
E25-4342
Proton craniospinal irradiation (pCSI) for leptomeningeal disease from solid tumors: feasibility, toxicity and clinical outcomes
Omer Gal, USA
E25-412
Repeat Chemoradiation vs. Re-Irradiation Alone in Recurrent Gliomas
Danielle Eekers, The Netherlands
E25-4346
Short term clinical outcomes after Linac based Stereotactic Radiosurgery Treatment of Deep Brain Arteriovenous Malformations (AVMs)
Zohreh Azma, Iran Islamic Republic of
E25-4373
Prognostic Validation of Brain Metastasis Velocity Metrics: Insights from a large Single-Institution Cohort Study
Sebastian Norbert Marschner, Germany
E25-4432
Adaptive radiotherapy in glioblastoma-what’s lurking behind the interim MRI?
Viktor Robert Paczona, Hungary
E25-4457
Does IDH-Mutant Astrocytoma have a better prognosis Than Glioblastoma?
Nejla Fourati, Tunisia
E25-4482
QSM Mapping Reveals Unique Vascular Signatures in Different Glioma Subtypes
Najmus Sahar Iqbal, United Kingdom
E25-4507
Stereotactic Radiotherapy + Systemic therapy for brain metastases from breast cancer: preliminary results of a multicentric retrospective study
Silvia Scoccianti, Italy
E25-4526